August 2011 | Oncology & Biotech News

September 01, 2011

Established in 1970 as a small clinic for cancer patients, the Georgetown Lombardi Comprehensive Cancer Center was named for football coach Vince Lombardi, who was treated for cancer at Georgetown University Hospital.

August 31, 2011

Fewer cancer patients need to be treated with denosumab to prevent one skeletal-related event due to bone metastases from solid tumors.

August 25, 2011

Flaxseed had no effect on reducing hot flashes in postmenopausal women who reported experiencing 28 or more hot flashes per week.

August 25, 2011

In late March, CMS ended the speculation by announcing its intention to pay for onlabel uses of the drug, which costs $93,000 for a 3-dose regimen, while leaving off-label coverage decisions to its regional contractors.

August 23, 2011

The following is a roundup of TPS abstracts that feature trials open to patients aged >17 years with a broad range of cancer types.

August 18, 2011

A survey of more than 2200 physicians indicated that cancer specialists and primary care physicians (PCPs) differ markedly in their concerns about the care that cancer survivors receive.

August 15, 2011

Bristol-Myers Squibb has agreed to purchase Amira Pharmaceuticals, a privately held biotech company, for $325 million and potential additional milestone payments of $150 million.

August 15, 2011

Treating myelofibrosis with the investigational JAK inhibitor ruxolitinib holds promise.

August 11, 2011

Dr Jimmie C. Holland was long convinced that psychological status was a critical factor not just in cancer management, but in illness more broadly.

August 08, 2011

Oncologists too often fail to detect the severe distress that can accompany a diagnosis and subsequent treatment.

August 08, 2011

In the context of caring for cancer patients, all physicians and nurses trained in oncology receive education in quality-of-life issues; however, prolonging quantity of life remains our ultimate goal.